Vaxcyte closes $1.15 billion public offerings
PCVX•Vaxcyte closed $1.15 billion in public offerings of common stock, pre-funded warrants and convertible senior notes.
1. Offering closed
Vaxcyte said it closed $1.15 billion in public offerings of common stock, pre-funded warrants and convertible senior notes.
